Reducing Oxidative Stress Through Photobiomodulation

Oxidative stress is implicated in the progression of over 200 human diseases and conditions, according to a landmark epidemiological review by Bhatt et al. (2020) in Antioxidants & Redox Signaling. The condition arises when the production of reactive oxygen species (ROS) — superoxide anion (O₂•⁻), hydrogen peroxide (H₂O₂), and hydroxyl radical (•OH) — outpaces the cell's endogenous antioxidant defenses. Left unchecked, ROS oxidize lipids, proteins, and DNA, impairing cellular function and accelerating biological aging.

Modern lifestyle factors — chronic psychological stress, processed-food diets, sedentary behavior, and environmental pollutants — all tilt the redox balance toward excess ROS production. The resulting low-grade oxidative stress is often subclinical, meaning it accumulates over years before manifesting as measurable organ dysfunction. This is why supporting the body's intrinsic antioxidant systems through non-pharmacological means has attracted substantial scientific interest. Photobiomodulation (PBM) has emerged as one of the most mechanistically coherent approaches to doing exactly that.

The relationship between PBM and ROS is paradoxical but well-characterized. During a brief, appropriately dosed light exposure, PBM actually generates a small, transient burst of ROS — specifically superoxide — from the mitochondrial electron transport chain. This seems counterproductive until one recognizes the concept of mitohormesis: a mild mitochondrial stress signal that activates powerful compensatory antioxidant programs.

This is analogous to the way exercise transiently raises ROS, which then triggers adaptations that make the cell far more oxidant-resistant. Research by de Freitas and Hamblin (2016) in IEEE Journal of Selected Topics in Quantum Electronics established that the transient ROS pulse from PBM is both dose-dependent and self-limiting — it activates NF-κB at sub-damaging concentrations, leading to upregulation of antioxidant enzymes rather than oxidative damage.

The most significant antioxidant consequence of PBM is activation of the Nrf2 (nuclear factor erythroid 2-related factor 2) transcription factor pathway. Under basal conditions, Nrf2 is sequestered in the cytoplasm by its repressor protein Keap1. Oxidative signals — including the mild ROS burst from PBM — cause conformational changes in Keap1 that release Nrf2. Freed Nrf2 translocates to the nucleus, where it binds the antioxidant response element (ARE) and drives transcription of dozens of cytoprotective genes including:

• Superoxide dismutase (SOD1, SOD2): Converts superoxide to the less reactive H₂O₂, first line of mitochondrial antioxidant defense.
• Catalase and glutathione peroxidase (GPx): Neutralize H₂O₂ into water and oxygen.
• Heme oxygenase-1 (HO-1): Produces biliverdin and carbon monoxide, both with anti-inflammatory and cytoprotective roles.
• Glutamate-cysteine ligase (GCL): Rate-limiting enzyme in glutathione synthesis; glutathione is the cell's primary water-soluble antioxidant.

A 2018 study by Huang et al. in Lasers in Medical Science demonstrated significant Nrf2 nuclear translocation and SOD2 upregulation in human skin fibroblasts after 850 nm irradiation at 6 J/cm², confirming the pathway activation in a clinically relevant cell type.

PBM's antioxidant effects are inseparable from its impact on mitochondrial energetics. When cytochrome c oxidase (CcO) is activated by photons, the mitochondrial membrane potential (ΔΨm) is restored or elevated. A well-maintained ΔΨm is associated with lower basal electron leak from Complexes I and III — the two major sites of superoxide generation during normal aerobic metabolism. In other words, the better the mitochondria run, the less accidental ROS they produce as a by-product.

This creates a self-reinforcing benefit: PBM increases ATP production while simultaneously reducing the chronic background ROS that mitochondria generate under stressed or dysregulated conditions. Clinical evidence supports this dual benefit. Tafur and Mills (2008) documented reduced plasma malondialdehyde (MDA) — a lipid peroxidation marker — in patients with chronic pain following a course of PBM, indicating systemic reduction in oxidative damage to lipids.

Monitoring oxidative stress reduction from PBM can be approached through several established biomarkers. The table below summarizes commonly used markers, their biological significance, and typical changes reported in PBM research:

Individuals interested in tracking objective outcomes from a PBM wellness routine may consider baseline measurements of MDA or CRP before beginning a protocol, then reassessing after 8–12 weeks.

The antioxidant effects of PBM are dose-dependent and require careful parameter selection. Excessively high fluences can shift from a hormetic stimulus to an oxidatively damaging one. Based on available literature, the following windows appear most supportive for redox balance:

• Wavelength: 810–860 nm NIR shows the strongest Nrf2 activation in deep tissue; 660 nm red is more effective for superficial skin-level antioxidant responses.
• Fluence: 3–10 J/cm² per session. The Nrf2-activating hormetic window appears to be between 2 and 15 J/cm², with diminishing returns above that threshold.
• Power density: 20–50 mW/cm² is effective for most applications. Higher irradiances may be used but require shorter exposure times to stay within the fluence window.
• Frequency: 4–5 sessions per week during an initial 8-week period, transitioning to 3 sessions per week for maintenance.
• Body areas: Systemic antioxidant effects may be best supported by applying light over large muscle groups (quadriceps, paraspinal muscles, trapezius) and the abdomen, where hepatic antioxidant enzyme activity can benefit from regional photostimulation.

Sustaining redox balance day-to-day calls for a consistent, low-barrier routine — which is precisely the use case that home NIR LED devices are designed to address. The CIRIUS NIR LED healthcare device delivers 850 nm near-infrared light in a format suited for daily wellness application. The 850 nm wavelength sits well within the NIR optical window associated with the Nrf2 activation and mitochondrial redox support described throughout this article.

For those interested in supporting their antioxidant capacity as part of a broader wellness lifestyle — alongside adequate sleep, an antioxidant-rich diet, and regular physical activity — the CIRIUS device may serve as a useful complementary tool. Apply it over large muscle groups or areas of habitual tension for 10–15 minutes per session, 4–5 times weekly, beginning with lower fluence exposures and increasing gradually. CIRIUS is a non-medical wellness device and does not claim to prevent, treat, or cure oxidative stress-related diseases. It is best understood as a supportive addition to a health-conscious daily routine.

PBM via NIR LED has an excellent safety profile when used within recommended parameters, but several considerations are important for responsible use:

• Eye protection: Never direct any LED light source toward the eyes. Use protective eyewear if applying near the face or scalp, and keep the beam away from eye level.
• Photosensitizing medications: Tetracycline antibiotics, fluoroquinolones, amiodarone, and certain antifungals increase photosensitivity. Consult a prescribing physician before incorporating PBM if you take any such medications.
• Skin integrity: Do not apply over open wounds, active skin infections, or areas of unknown dermatological pathology without professional guidance.
• Thyroid and malignancy: Avoid direct application over the thyroid gland or any known active malignancy. The safety data in these specific scenarios is insufficient to support use.
• Medical evaluation: PBM is a wellness-support tool. Persistent fatigue, chronic pain, or other systemic symptoms that may reflect underlying oxidative stress-related pathology warrant evaluation by a qualified healthcare provider, not solely a home wellness device.